Global private equity and venture capital news and research

US biotech company Alios BioPharma gets $8m backing from GlaxoSmithKline’s venture arm

23 Jun 2009

Alios BioPharma, an emerging US biotech company that is developing medicines to treat viral diseases by activating pathways in the innate immune system, has closed a $32m Series A funding round.

Sorry, to get access to this you need to subscribe for free.

In order to view more content, sign-up to our free daily newsletter.

If you would like to read the premium stories, have complete access to our breaking news and Limited Partner magazine you need to become a Premium Subscriber.

Subscribe to AltAssets today

Login to AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016